You just read:

Neurotrope Selects Worldwide Clinical Trials to Commence Services for Phase 2B Trial of Bryostatin for the Treatment of Alzheimer's Disease

News provided by

Neurotrope, Inc.

Apr 06, 2015, 08:00 ET